Clinical Trial Update: Steroids Added to Dithranol and Narrow Band UVB(Ultraviolet B) (UVBnb) in Psoriasis [Phase 4]

View source ↗

Summary

A Phase 4 psoriasis trial evaluating the combination of steroids with dithranol and narrow-band UVB has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Dithranol (anthralin)
• Topical corticosteroid (corticosteroid)

Snippet

Sponsor: University of Zurich | Conditions: Psoriasis | Phase 4 | Status: WITHDRAWN